AN-019
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic myelogenous leukemia (CML) and breast cancer.
Product Specifications
CAS Number
879507-25-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
517.43
Molecular Formula
C25H17F6N5O
Notes
Research use only, not for human use.
Receptor
Bcr-Abl
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog